Detalhe da pesquisa
1.
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium.
Mod Pathol
; 37(7): 100497, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641322
2.
Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
Ann Surg Oncol
; 31(4): 2244-2252, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38161200
3.
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719547
4.
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 84(7): 1111-1129, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443320
5.
NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
Mod Pathol
; 36(6): 100144, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828363
6.
Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals.
Mod Pathol
; 36(6): 100121, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889065
7.
Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity.
Mod Pathol
; 35(10): 1370-1382, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477749
8.
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer.
Mod Pathol
; 35(12): 1812-1820, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922548
9.
Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision.
Ann Surg Oncol
; 29(3): 1660-1667, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34554341
10.
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
Ann Surg Oncol
; 29(12): 7696-7702, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771367
11.
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer.
Ann Surg Oncol
; 29(12): 7726-7736, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810224
12.
Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy.
Mod Pathol
; 34(Suppl 1): 1-7, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32908254
13.
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer.
Mod Pathol
; 34(5): 875-882, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219297
14.
Testosterone therapy and breast histopathological features in transgender individuals.
Mod Pathol
; 34(1): 85-94, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939016
15.
Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 28(12): 7347-7355, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956276
16.
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
Ann Surg Oncol
; 28(5): 2573-2578, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33047246
17.
Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.
Ann Surg Oncol
; 28(12): 7404-7409, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990927
18.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
; 250(5): 667-684, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129476
19.
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.
Mod Pathol
; 33(7): 1287-1297, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31932682
20.
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
Mod Pathol
; 33(6): 1056-1064, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31896809